EQS-News: Continued strong performance in the third quarter of 2023
The third quarter saw revenues of €617 million (Q3 2022: €698 million) including only €4 million from COVID-19 testing (Q3 2022: €102 million).
- The third quarter saw revenues of €617 million (Q3 2022: €698 million) including only €4 million from COVID-19 testing (Q3 2022: €102 million).
- Q3 2023 underlying growth was 5.1% with strong volume growth of 3.5% and price increase of 1.6%.
- Synnovis, the South East London hospital outsourcing contract grew 14.3% in Q3 2023 and contributed 1.9pts of the overall Q3 2023 underlying growth.
- €200 million TLA debt was subsequently reimbursed in Q4 2023 following the sale of the Veterinary business at the end of September 2023.